Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2019 (fr)
- im Oktober 2019 veröffentlichter wissenschaftlicher Artikel (de)
- наукова стаття, опублікована в жовтні 2019 (uk)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Daniel Scott
- Edward E Walsh
- Beate Schmoele-Thoma
- David Radley
- Agnieszka Zareba
|
rdfs:label
| - 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (en)
- 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (nl)
|
skos:prefLabel
| - 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (en)
- 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (nl)
|
name
| - 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (en)
- 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (nl)
|
author
| |
author
| |
title
| |
title
| - 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
copyright license
| |
copyright status
| |
copyright license
| |
copyright status
| |
PMCID
| |
PMCID
| |
is about
of | |